首頁 > 市場調查報告書 > 製藥

藥物開發開發業務受託機關

歐洲藥品合約銷售組織市場預測至 2030 年 - 區域分析 - 按服務、模組、治療領域和最終用戶

市場調查報告書

商品編碼

1494477

歐洲藥品合約銷售組織市場預測至 2030 年 - 區域分析 - 按服務、模組、治療領域和最終用戶

Europe Pharmaceutical Contract Sales Organizations Market Forecast to 2030 - Regional Analysis - by Services, Modules, Therapeutic Area, and End User

出版日期: 2024年04月05日 | 出版商:

The Insight Partners | 英文 88 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

歐洲藥品合約銷售組織市場預計將從2022年的19.089億美元成長到2030年的34.7497億美元。

製藥公司對增加產品銷售的興趣日益濃厚，推動了歐洲藥品合約銷售組織市場

近年來，製藥公司擴大採用創新策略來增加其產品的銷售量。這一領域的一個顯著趨勢是對藥品合約銷售組織 (CSO) 的高度依賴，將其作為其商業化努力的關鍵組成部分。這凸顯了製藥實體為應對市場複雜性而採取的積極主動的方法。透過與公民社會組織合作，這些公司可以利用專業的銷售隊伍，利用外部熟練度來提高市場滲透率並最佳化銷售業績。這種協作模式使製藥公司能夠簡化營運並專注於研發等核心能力，同時利用公民社會組織的客製化專業知識來增強其產品的市場地位。製藥公司和公民社會組織之間日益增強的協同反映了對資源最佳化的細緻入微的理解，體現了對適應性的承諾以及對激烈競爭的製藥領域不斷變化的動態的敏銳認知。這種共生關係促進了收入最大化，並使製藥企業在敏捷性和有針對性的市場策略對於持續成功至關重要的環境中進行策略定位。

歐洲藥品合約銷售組織市場概況

歐洲藥品合約銷售組織市場分為德國、英國、法國、義大利、西班牙和歐洲其他地區。隨著慢性病盛行率的迅速上升、老年人口的不斷增加以及各種治療應用對新藥物分子的需求不斷增加，以滿足未滿足的需求，該地區對藥品的需求正在顯著成長。近 550 家製藥公司在德國開展業務。該國的合約銷售組織（CSO）為大型製藥公司和小型生物技術公司提供服務，幫助他們在歐洲市場取得領先地位。根據德國貿易投資總署的資料，2020年德國藥品銷售額較2019年成長6.7%，達607.9億美元（495億歐元）。近年來，由於生物藥物的發展，德國和其他歐洲國家的製藥業模式發生了重大變化。因此，生物製劑因其強大的治療潛力而佔據了製藥業務的相當大一部分。大公司現在專注於創造複雜的生物化合物，而不是開發小分子藥物。

2021年3月，IQVIA與強生公司子公司楊森製藥公司之一的Janssen Research & Development, LLC合作進行楊森的COVID-19疫苗的3期臨床試驗。這些試驗結合了遠距醫療技術、虛擬監督和數位患者互動策略，利用了 IQVIA 的一系列分散式試驗解決方案，並得到了現場和遠端研究的支持。 IQVIA 擁有全球最大的商業解決方案組織，致力於推出和行銷各種客戶產品，該公司在歐洲多個國家都有業務。

歐洲藥品合約銷售組織市場收入和 2030 年預測（百萬美元）

歐洲藥品合約銷售組織市場區隔

歐洲藥品合約銷售組織市場分為服務、模組、治療領域、最終用戶和國家。

根據服務，歐洲藥品合約銷售組織市場分為商業服務和非商業服務。 2022年，商業服務領域在歐洲藥品合約銷售組織市場中佔有更大佔有率。

根據模組，歐洲藥品合約銷售組織市場分為聯合模組和專用模組。 2022 年，聯合模組細分市場在歐洲藥品合約銷售組織市場中佔據更大佔有率。

根據治療領域，歐洲藥品合約銷售組織市場分為心血管疾病、腫瘤、代謝性疾病、神經科、骨科疾病、傳染病等。 2022 年，腫瘤學領域在歐洲藥品合約銷售組織市場中佔據最大佔有率。

根據最終用戶，歐洲藥品合約銷售組織市場分為生物製藥公司和製藥公司。 2022 年，製藥公司細分市場在歐洲藥品合約銷售組織市場中佔有更大佔有率。

根據國家/地區，歐洲藥品合約銷售組織市場分為英國、德國、法國、西班牙、義大利和歐洲其他地區。 2022 年，德國在歐洲藥品合約銷售組織市場佔據主導地位。

Aenova Holding GmbH、IQVIA Holdings Inc、MaBico SA、輝瑞公司和 Syneos Health Inc 是歐洲藥品合約銷售組織市場上的一些領先公司。

In recent years, pharmaceutical companies are increasingly adopting innovative strategies to augment the sales of their products. One notable trend within this landscape is the heightened reliance on pharmaceutical contract sales organizations (CSOs) as a pivotal component of their commercialization endeavors. This underscores a proactive approach by pharmaceutical entities to navigate the complexities of the market. By engaging CSOs, these companies can tap into specialized sales forces, capitalizing on external proficiency to enhance market penetration and optimize sales performance. This collaborative paradigm enables pharmaceutical firms to streamline their operations and concentrate on core competencies such as research and development while concurrently leveraging the tailored expertise of CSOs to bolster their products' market presence. The growing synergy between pharmaceutical companies and CSOs reflects a nuanced understanding of resource optimization, illustrating a commitment to adaptability and a keen awareness of the evolving dynamics within the fiercely competitive pharmaceutical landscape. This symbiotic relationship facilitates revenue maximization and positions pharmaceutical enterprises strategically in an environment where agility and targeted market strategies are paramount for sustained success.

Europe Pharmaceutical Contract Sales Organizations Market Overview

The European pharmaceutical contract sales organizations market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The demand for pharmaceutical products is growing significantly in this region with the burgeoning prevalence of chronic diseases, the rising geriatric population, and increasing demand for new drug molecules for various therapeutic applications to fulfill unmet needs. Nearly 550 pharmaceutical companies have operations in Germany. Contract sales organizations (CSOs) in this country provide their services to large pharmaceutical companies and small-scale biotech companies, assisting them in attaining leading positions in the European market. As per data by Germany Trade & Invest, pharmaceutical sales in Germany increased by 6.7% in 2020 compared to 2019, reaching US$ 60.79 billion (EUR 49.5 billion). The landscape of the pharmaceutical industry in Germany and other European countries has recently undergone significant changes due to the development of biological medications. As a result, biologics have taken up a sizeable portion of pharmaceutical businesses due to their strong therapeutic potential. Large corporations are now concentrating on creating complex biological compounds rather than developing small-molecule drugs.

In March 2021, IQVIA worked with Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies, which is a subsidiary of Johnson & Johnson, on the Phase 3 clinical trials of Janssen's COVID-19 vaccine. Combining telehealth technologies, virtual oversight, and digital patient interaction tactics, the trials leveraged IQVIA's array of decentralized trial solutions, which were supported by on-site and remote studies. IQVIA has the world's largest commercial solutions organization dedicated to launching and marketing various clients' products, and the company has presence in various European countries.

Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Million)

Europe Pharmaceutical Contract Sales Organizations Market Segmentation

The Europe pharmaceutical contract sales organizations market is segmented into services, modules, therapeutic area, end user, and country.

Based on services, the Europe pharmaceutical contract sales organizations market is bifurcated into commercial services and non-commercial services. The commercial services segment held a larger share of the Europe pharmaceutical contract sales organizations market in 2022.

Based on modules, the Europe pharmaceutical contract sales organizations market is bifurcated into syndicated modules and dedicated modules. The syndicated modules segment held a larger share of the Europe pharmaceutical contract sales organizations market in 2022.

Based on therapeutic area, the Europe pharmaceutical contract sales organizations market is segmented into cardiovascular disorders, oncology, metabolic disorders, neurology, orthopedic diseases, infectious diseases, and others. The oncology segment held the largest share of the Europe pharmaceutical contract sales organizations market in 2022.

Based on end user, the Europe pharmaceutical contract sales organizations market is bifurcated into biopharmaceutical companies and pharmaceutical companies. The pharmaceutical companies segment held a larger share of the Europe pharmaceutical contract sales organizations market in 2022.

Based on country, the Europe pharmaceutical contract sales organizations market is segmented into the UK, Germany, France, Spain, Italy, and the Rest of Europe. Germany dominated the Europe pharmaceutical contract sales organizations market in 2022.

Aenova Holding GmbH, IQVIA Holdings Inc, MaBico SA, Pfizer Inc, and Syneos Health Inc are some of the leading companies operating in the Europe pharmaceutical contract sales organizations market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Pharmaceutical Contract Sales Organizations Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 Europe PEST Analysis

5. Europe Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics

5.1 Key Market Drivers
- 5.1.1 Increasing Integration of Digital Technologies
- 5.1.2 Growing Interest of Pharmaceutical Companies to Increase Sales of Products
5.2 Key Market Restraints
- 5.2.1 Quality Issues Associated with Outsourcing
5.3 Key Market Opportunities
- 5.3.1 Rising Use of Telemedicine and Remote Detailing
5.4 Key Future Trends
- 5.4.1 Expansion in Emerging Markets
5.5 Impact Analysis:

6. Pharmaceutical Contract Sales Organizations Market - Europe Market Analysis

6.1 Europe Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030

7. Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Services

7.1 Overview
7.2 Europe Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)
7.3 Commercial Services
- 7.3.1 Overview
- 7.3.2 Commercial Services: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Non-Commercial Services
- 7.4.1 Overview
- 7.4.2 Non-Commercial Services: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Modules

8.1 Overview
8.2 Europe Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)
8.3 Syndicated Modules
- 8.3.1 Overview
- 8.3.2 Syndicated Modules: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Dedicated Modules
- 8.4.1 Overview
- 8.4.2 Dedicated Modules: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Therapeutic Area

9.1 Overview
9.2 Europe Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)
9.3 Cardiovascular Disorders
- 9.3.1 Overview
- 9.3.2 Cardiovascular Disorders: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Oncology
- 9.4.1 Overview
- 9.4.2 Oncology: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Metabolic Disorders
- 9.5.1 Overview
- 9.5.2 Metabolic Disorders: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Neurology
- 9.6.1 Overview
- 9.6.2 Neurology: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.7 Orthopaedic Diseases
- 9.7.1 Overview
- 9.7.2 Orthopedic Diseases: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.8 Infectious Diseases
- 9.8.1 Overview
- 9.8.2 Infectious Diseases: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.9 Others
- 9.9.1 Overview
- 9.9.2 Others: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by End User

10.1 Overview
10.2 Europe Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
10.3 Biopharmaceutical Companies
- 10.3.1 Overview
- 10.3.2 Biopharmaceutical Companies: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Pharmaceutical Companies
- 10.4.1 Overview
- 10.4.2 Pharmaceutical Companies: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)

11. Europe Pharmaceutical Contract Sales Organizations Market - Country Analysis

11.1 Europe Pharmaceutical Contract Sales Organizations Market, Revenue and Forecast to 2030

12. Pharmaceutical Contract Sales Organizations Market - Industry Landscape

12.1 Overview
12.2 Growth Strategies
- 12.2.1 Overview

13. Company Profiles

13.1 MaBico SA
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 IQVIA Holdings Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Syneos Health Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Aenova Holding GmbH
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Pfizer Inc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments

14. Appendix

14.1 About Us
14.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. Europe Pharmaceutical Contract Sales Organizations Market Segmentation
Table 2. UK: Europe Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 3. UK: Europe Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 4. UK: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 5. UK: Europe Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 6. Germany: Europe Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 7. Germany: Europe Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 8. Germany: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 9. Germany: Europe Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 10. France: Europe Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 11. France: Europe Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 12. France: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 13. France: Europe Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 14. Italy: Europe Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 15. Italy: Europe Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 16. Italy: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 17. Italy: Europe Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 18. Spain: Europe Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 19. Spain: Europe Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 20. Spain: Europe Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 21. Spain: Europe Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 22. Rest of Europe: Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 23. Rest of Europe: Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 24. Rest of Europe: Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 25. Rest of Europe: Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 26. Recent Growth Strategies in the Pharmaceutical Contract Sales Organizations Market
Table 27. Glossary of Terms, Europe Pharmaceutical Contract Sales Organizations Market

List Of Figures

Figure 1. Europe Pharmaceutical Contract Sales Organizations Market Segmentation, By Country
Figure 2. Europe PEST Analysis
Figure 3. Europe Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Europe Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030
Figure 6. Europe Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)
Figure 7. Commercial Services: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Non-Commercial Services: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Europe Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)
Figure 10. Syndicated Modules: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Dedicated Modules: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Europe Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)
Figure 13. Cardiovascular Disorders: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Oncology: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Metabolic Disorders: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Neurology: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Orthopedic Diseases: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Infectious Diseases: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Europe Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 21. Biopharmaceutical Companies: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Pharmaceutical Companies: Europe Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Europe Pharmaceutical Contract Sales Organizations Market, by Key Country - Revenue, 2022 (US$ Million)
Figure 24. Europe Pharmaceutical Contract Sales Organizations Market, By Key Countries, 2022 and 2030 (%)
Figure 25. UK: Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. Germany: Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. France: Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Italy: Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. Spain: Europe Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. Rest of Europe: Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)